Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Yongxu PiaoDepartment of Dentistry, Jiangsu Vocational College of Medicine, Yancheng 224005, China.ORCID 0009-0009-0983-4195
Xiangguo CheDepartment of Biochemistry and Cell Biology, Cell and Matrix Research Institute, Skeletal Disease Center, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-7272-1806
Xian JinDepartment of Biochemistry and Cell Biology, Cell and Matrix Research Institute, Skeletal Disease Center, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-8273-0108
Dong-Kyo LeeDepartment of Biochemistry and Cell Biology, Cell and Matrix Research Institute, Skeletal Disease Center, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
Min ParkDepartment of Biochemistry and Cell Biology, Cell and Matrix Research Institute, Skeletal Disease Center, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0009-0005-6047-4667
Eun-Jung HeoDepartment of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.
Jinyoung OhDepartment of Anesthesiology and Pain Medicine, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0003-3562-908X
Seong-Gon KimDepartment of Oral and Maxillofacial Surgery, College of Dentistry, Gangneung-Wonju National University, 7 Jukheon-gil, Gangneung-si 25457, Republic of Korea.ORCID 0000-0001-5088-2732
Dae-Chul ChoDepartment of Neurosurgery, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, 130 Dongduk-Ro, Jung-Gu, Daegu 41944, Republic of Korea.
Hyun-Ju KimDepartment of Biochemistry and Cell Biology, Cell and Matrix Research Institute, Skeletal Disease Center, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-5836-5841
Je-Yong ChoiDepartment of Biochemistry and Cell Biology, Cell and Matrix Research Institute, Skeletal Disease Center, School of Medicine, Kyungpook National University, Daegu 41944, Republic of Korea.ORCID 0000-0002-5057-8842
Funding
National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) RS-2022-NR069290National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) RS-2025-23963008Research Initiation Funding Project of Jiangsu Medical College 2024610
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
bone remodelingchemotaxisFollistatin-like 1mesenchymal stem cellosteoblast differentiationosteoclast differentiationosteoporosis therapy
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
The Role of Follistatin-like 1 in the Cross-Talk Among Osteoclastogenesis, Bone Marrow Stromal Cell Migration, and Osteoblastogenesis · full record | OpenQuestion